BANK OF AMERICA CORP /DE/

Bank

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 70858 CHARLOTTE, NC

Position in OBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$102,791

-$121,443 QoQ

Shares Held

23,822

-54.8% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 77 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,049,375,424 across 337 Biotechnology names. OBIO ranks #309 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,039,178	$1,509,650,884
2	REGN	Regeneron Pharmaceuticals, Inc.	1,291,053	$805,023,185
3	CYTK	Cytokinetics Inc	4,635,709	$394,916,048
4	ARGX	Argenx SE	400,234	$371,325,094
5	ALNY	Alnylam Pharmaceuticals, Inc.	994,476	$299,367,107
6	JAZZ	Jazz Pharmaceuticals plc	1,136,091	$273,763,844
7	TVTX	Travere Therapeutics, Inc.	4,568,341	$259,527,450
8	RPRX	Royalty Pharma plc	4,149,422	$232,658,090

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$102,791	23,822	-54.8%	Shares	Defined	2026-08-14
2026-03-31	$224,234	52,761	+200.7%	Shares	Defined	2026-05-18
2025-12-31	$72,819	17,547	-43.6%	Shares	Defined	2026-02-17
2025-09-30	$77,175	31,119	+44.2%	Shares	Defined	2026-02-03
2025-06-30	$57,825	21,577	+35.7%	Shares	Defined	2025-08-14
2025-03-31	$68,047	15,899	-33.1%	Shares	Defined	2025-05-15
2024-12-31	$95,120	23,780	+42.0%	Shares	Defined	2025-02-14
2024-09-30	$86,063	16,744	+6.2%	Shares	Defined	2024-11-14
2024-06-30	$128,524	15,770	+254.5%	Shares	Defined	2024-08-14
2024-03-31	$23,439	4,448	-90.2%	Shares	Defined	2024-05-15
2023-12-31	$414,757	45,428	+610.4%	Shares	Defined	2024-02-14
2023-09-30	$55,764	6,395	+474.1%	Shares	Defined	2023-11-14
2023-06-30	$7,798	1,114	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.